221 related articles for article (PubMed ID: 37162929)
21. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
[TBL] [Abstract][Full Text] [Related]
22. Mediators and mechanisms of immune checkpoint inhibitor-associated myocarditis: Insights from mouse and human.
Gong J; Neilan TG; Zlotoff DA
Immunol Rev; 2023 Sep; 318(1):70-80. PubMed ID: 37449556
[TBL] [Abstract][Full Text] [Related]
23. Peripheral immune mapping and multi-omics analysis in Pd-1 inhibitor-induced myocarditis.
Gao J; Wang Y; Lu L; Ma M; Ling J; Sun L; Chen Y; Liu F; Yu Y; Liu T; Wu D
J Leukoc Biol; 2023 Jul; 114(2):164-179. PubMed ID: 37202883
[TBL] [Abstract][Full Text] [Related]
24. Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program.
Naqash AR; Moey MYY; Cherie Tan XW; Laharwal M; Hill V; Moka N; Finnigan S; Murray J; Johnson DB; Moslehi JJ; Sharon E
J Clin Oncol; 2022 Oct; 40(29):3439-3452. PubMed ID: 35658474
[TBL] [Abstract][Full Text] [Related]
25. Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms.
Champion SN; Stone JR
Mod Pathol; 2020 Jan; 33(1):99-108. PubMed ID: 31534205
[TBL] [Abstract][Full Text] [Related]
26. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.
Daunke T; Beckinger S; Rahn S; Krüger S; Heckl S; Schäfer H; Wesch D; Pilarsky C; Eckstein M; Hartmann A; Röcken C; Wandmacher AM; Sebens S
Front Immunol; 2023; 14():1157397. PubMed ID: 37449210
[TBL] [Abstract][Full Text] [Related]
27. Cardiac Complications in Immune Checkpoint Inhibition Therapy.
Tajiri K; Ieda M
Front Cardiovasc Med; 2019; 6():3. PubMed ID: 30729114
[TBL] [Abstract][Full Text] [Related]
28. Icaritin inhibited cigarette smoke extract-induced CD8
Li Q; Sun J; Cao Y; Liu B; Zhao Z; Hu L; Zhang H; Kong Q; Wu J; Dong J
Phytomedicine; 2022 Feb; 96():153907. PubMed ID: 35026517
[TBL] [Abstract][Full Text] [Related]
29. Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma.
Wang Y; Zhang X; Xu C; Nan Y; Fan J; Zeng X; Kwon BS; Ju D
Front Immunol; 2022; 13():1004475. PubMed ID: 36544785
[TBL] [Abstract][Full Text] [Related]
30. Immunopathogenesis of Immune Checkpoint Inhibitor Induced Myocarditis: Insights from Experimental Models and Treatment Implications.
Wong CK; Lam TH; Liao SY; Lau YM; Tse HF; So BYF
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672615
[TBL] [Abstract][Full Text] [Related]
31. Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge.
Frascaro F; Bianchi N; Sanguettoli F; Marchini F; Meossi S; Zanarelli L; Tonet E; Serenelli M; Guardigli G; Campo G; Calabrò L; Pavasini R
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137806
[TBL] [Abstract][Full Text] [Related]
32. ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis.
Horiguchi H; Kadomatsu T; Yamashita T; Yumoto S; Terada K; Sato M; Morinaga J; Miyata K; Oike Y
Commun Biol; 2023 Sep; 6(1):965. PubMed ID: 37736764
[TBL] [Abstract][Full Text] [Related]
33. The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi.
Hardison JL; Wrightsman RA; Carpenter PM; Lane TE; Manning JE
Infect Immun; 2006 Jan; 74(1):125-34. PubMed ID: 16368965
[TBL] [Abstract][Full Text] [Related]
34. Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies.
Ronen D; Bsoul A; Lotem M; Abedat S; Yarkoni M; Amir O; Asleh R
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455289
[TBL] [Abstract][Full Text] [Related]
35. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
[TBL] [Abstract][Full Text] [Related]
36. Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Nuñez NG; Berner F; Friebel E; Unger S; Wyss N; Gomez JM; Purde MT; Niederer R; Porsch M; Lichtensteiger C; Kramer R; Erdmann M; Schmitt C; Heinzerling L; Abdou MT; Karbach J; Schadendorf D; Zimmer L; Ugurel S; Klümper N; Hölzel M; Power L; Kreutmair S; Capone M; Madonna G; Cevhertas L; Heider A; Amaral T; Hasan Ali O; Bomze D; Dimitriou F; Diem S; Ascierto PA; Dummer R; Jäger E; Driessen C; Levesque MP; van de Veen W; Joerger M; Früh M; Becher B; Flatz L
Med; 2023 Feb; 4(2):113-129.e7. PubMed ID: 36693381
[TBL] [Abstract][Full Text] [Related]
37. Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms.
Rikhi R; Karnuta J; Hussain M; Collier P; Funchain P; Tang WHW; Chan TA; Moudgil R
Front Cardiovasc Med; 2021; 8():721333. PubMed ID: 34434981
[TBL] [Abstract][Full Text] [Related]
38. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
39. Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.
Racine JJ; Bachman JF; Zhang JG; Misherghi A; Khadour R; Kaisar S; Bedard O; Jenkins C; Abbott A; Forte E; Rainer P; Rosenthal N; Sattler S; Serreze DV
J Immunol; 2024 Apr; 212(8):1287-1306. PubMed ID: 38426910
[TBL] [Abstract][Full Text] [Related]
40. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
Front Immunol; 2022; 13():879900. PubMed ID: 35924238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]